Hwa An Reports May 2026 Revenue of NT$0.01 Billion (YoY -24.1%)
AI Summary (NQ-processed)
Hwa An (stock code: 6657), a biotechnology and healthcare company, announced its revenue for May 2026 at NT$541 thousand (approximately USD$0.01 billion), representing a 24.1% year-on-year decline, signaling ongoing challenges in the biotech healthcare sector.
AI Analysis
Frequently Asked Questions
Q: What was Hwa An's revenue in May 2026?
A: NT$541 thousand (0.01 billion), down 24.1% year-on-year.
Q: What industry is Hwa An in?
A: It operates in the biotechnology healthcare sector, focusing on medical technology and biotech product development.
Q: What factors contributed to this performance?
A: Possible causes include intensified competition, delayed product approvals, and weakening demand.